Purpose
To enhance knowledge of hemophilia management utilizing current literature review, shared experiences, and networking among hemophilia treatment center (HTC) nurses
Objectives
Upon completion of this learning activity, you will be able to:
- Discuss considerations, controversies, and resources in the management of hemophilia in women
- Characterize inhibitor development, risk factors, and treatment methods in different types of hemophilia
- Apply clinical decision-making in individualized prophylactic therapy of persons with hemophilia
- Review FVIII immune tolerance regimens and expected outcomes for persons with hemophilia with FVIII inhibitors
- Survey the rapidly evolving landscape of hemophilia treatment options
- Assess orthopedic challenges and interventions for individuals with hemophilia
Target Audience
Nurses, nurse practitioners, physician assistants and pharmacists practicing in the U.S. federally funded network of HTCs
Continuing Education
In support of improving patient care, this activity has been planned and implemented by University of Nebraska Medical Center and Partners in Bleeding Disorders Education Program. The University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Eligibility Criteria
To attend this program, you must meet the following criteria:
- Be employed at a U.S. federally funded HTC as a nurse, nurse practitioner, physician assistant, or similar role for at least 2 years.
- Obtain approval to attend from Regional Coordinator via automated process upon submission of application.
Cost and Travel Information
There is no registration fee to attend Advanced Nursing Topics I.
Funding to support the Partners in Bleeding Disorders Education Program is provided through an unrestricted educational grant from Shire. The Partners in Bleeding Disorders Education Program: Advanced Nursing Topics I is supported by an educational grant from Genentech. Travel and lodging for program participants are made possible by an at-will contribution from the Indiana Hemophilia and Thrombosis Center.
Once registered, you will be contacted approximately 4 weeks before the program with instructions on scheduling your flight or rental car.
All registrants are encouraged to read the Partners Travel Policy to understand costs that are covered and costs that you may incur.
Annual Dates
Application Form
Apply Now